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Spleen cells stimulated by concanavalin A  (Con A) produce a  factor or factors (T 
celt-growth  factor  [TCCF]), TCGF-S, that  stimulates T  cell  replication (1-9).  The 
production of TCGF-S involves at least two cell types, a  Thy-1 + cell and an Ia  + cell 
(1, 2). The subpopulation of T  cells that yields TCGF-S appears to be Lyt-1 +2-3- (3- 
5,  I0). It is not known if TCGF activity is the property of a  single molecule or of a 
group of related molecules. 
The results reported here derive from a  search  for a  TCGF-producing tumor cell 
line.  Although  no cell  line examined yielded TCGF spontaneously,  1 of  12  (EL-4 
azg  r) T-lymphoma cell lines and, to a  lesser extent, the parental EL-4 line, produced 
TCGF  (TCGF-E) when stimulated by T  mitogens; the TCGF-E produced has  the 
molecular size and functional properties of TCGF-S. 
Materials and Methods 
Tumor Cell Lines.  The EL-4 cell line was originally obtained from Dr. D. B. Amos, and the 
EL-4  azaguanine-resistant (EL-4  azg  ~)  cell  line was established in this laboratory and main- 
tained in the medium that contained 100~M 8-azaguanine. These lines were Lyt-1 +, Lyt-2-3-, 
and Thy-1 +, on repeated testing with monoclonal antibody. Other T-lymphoma cell lines were 
obtained from the Salk Institute for Biological Studies, San Diego, Calif. and have the markers 
indicated in Table I. 
Induction of TCGFProduction+  Various numbers of cells (1 X 10%4  X 106) of  each T-lymphoma 
cell  line were  cultured with  or without  a  mitogen  (Con A,  phytohemagglutinin IPHA-P], 
pokeweed  mitogen [PWM], or lipopolysaccharide [LPS])  in 2 ml RPMI-1640 supplemented 
with 2.5% or 5% fetal calf serum (FCS), 5 ×  10  -5 M, 2-mercaptoethanol (2ME), 10 mM Hepes, 
and antibiotics in 24-well plates (Linbro Chemical Co., Hamden, Conn.). The cultures were 
incubated in a humidified atmosphere of 5% COz in air at 37°C. The supernatant media were 
harvested after various durations (3-36 h) and filtered through 0.22-p,m filters  and stored at 
-20"C until use. 
Assay  CeUsfor  TCGF.  Culture supernates or fractions obtained by chromatography were 
assayed  for TCGF activity primarily on a cloned C57BL/6 anti-DBA/2 cytotoxic T  cell line 
(BAD-I, Lyt-l-2+3  +) that was developed and maintained in this laboratory (11) for >18 mo. 
This line is absolutely TCGF dependent and it does not proliferate in response to mitogens or 
antigen. In addition to  this line, TCGF-E activity was  assayed  on a  C57BL/6 anti-DBA/2 
alloreactive cell line (BADCXA-2, Lyt-1+2-3-), Con-A-stimulated  T cell blasts, LPS-stimulated 
B cell blasts, thymocytes, and nylon-wool-column-passed  spleen cells. 
Assay of TCGF Activity.  The method of Gillis et al.  (12) was modified as follows: assay cells 
were washed and resuspended in RPMI-1640 with 2.5% FCS, 5 ×  10  -'~ M 2ME, 10 mM Hepes, 
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TAnLE I 
Mitogen-inducod TCGF Production by T-Lyrnphoma Cell Lines* 
Ceil line tested 
Surface antigen  Mitogen-induced TCGF activity by mitogen§ 
markers*  Spontaneous 
secretion of 
TCGF  Con A  PHA-P  PWM  LPS 
Thy-l.2  Lyt-1  Lyt-2  (5 ~g/ml)  (1 ~al/ml)  (10/~l/ml)  (10 ~g/ml) 
EL-4  +  +  -  702  u  (0.91)I  5,294 (6.9)  869 (I.I)  898 (I.2)  1,186 (1.5) 
EL-4 azg'  +  +  -  1,021  (1.3)  17,1}82  (22.2)  2,600 (3.4)  1,101  (I.4)  3,779 (4.9) 
BW5147  -  -  --  588  (0.88)  599 (0.78)  260 (0.34)  1,014  (I.3)  903 (I.2) 
BW5147 GI.4.  -  -  -  720  (0.93)  707 (0.92)  380 (0.50)  942 (I.2)  966 (I.3) 
BW5147 GI.4. Pus ~  -  -  -  688  (0.90)  719 (0.94)  309 (0.40)  851  (I.I)  766 (I.0) 
T1MI.4.G.I.3  +  -  :l=**  633  (0.82)  564 (0.73)  326 (0.42)  677 (0.88)  859 (1.1) 
$49.1G.3  +  -  -  530  (0.69)  583 (0.76)  282 (0.37)  590 (0.77)  743 (0.97) 
$49 Thy-I-  -  -  -  436  (0.57)  437 (0.57)  246 (0.32)  480 (0.63)  520 (0.68) 
R  1.1.  +  -  -  689  (0.90)  732 (0.94)  351  (0.46)  754 (0.98)  746 (0.97) 
R  I.GI.  +  -  -  713  (0.93)  696 (0.91)  425 (0.55)  769 (1.0)  859 (1.2) 
WEHI-7  +  -  -  497  (0.64)  784 (I.0)  476 (0.62)  734 (0.96)  818 (1.1) 
WEHI-22.1  +  -  -  604  (0.79)  655 (0.85)  373 (0.49)  654 (0.85)  787 (I.0) 
* In this experiment, control (medium) incorporation was 768 :t: 61 cpm and 7- or 28-times-concentrated EL-4 azg' supernates 
were 854 3:113 or 1,10t 3:15 cpm, respectively. Cell extracts of EL-4 azg  r made by freeze-thawing three times gave 758 3:49 
cpm;  TCGF-S  at  25%  concentration  gave  10,192  3:635  cpm and  at  12%  gave 7,775  3:  1,395;  purified  TCGF-S  at  25% 
concentration gave 22,006 :t:  14.9 cpm. TCGF-E obtained from irradiated EL-4 azg' (5,000 or 7,000 tad) plus Con A  (5 #g/ml) 
gave 16,832 3:1,013 and  16,901  3:  1,333,  respectively. 
:~ EL-4 and EL-azg  r were T-200  ÷. All lines are sIg-. Thy-l, Lyt, and "1"-200 were determined by indirect  immunofluorescence 
assay with monoclonal antibody, and slg by direct immunofluorescence. 
§  I  ×  106 cells/ml of each cell line were cultured with or without  a  mitogen in 2  ml of 2.5%-FCS culture medium in 24-well 
plates. After 18 h of cuhure, supernates were assayed for TCGF activity on cell line BAD-I. [aH]thymidine incorporation was 
measured for the last 6 h  of the 28-h incubation. 
[I [SH]thymidine incorporation (mean cpm). 
¶ Stimulation index; mean [aH]thymidine incorporation of experiment/contro|. 
** Minimal but detectable binding of anti-Lyt-2 monoclonal antibody. 
and  antibiotics.  5  ×  104  cells  in  100  #1  medium  were  placed  in  96-well  round-bottomed 
microplate (Linbro Chemical  Co.)  followed by  100 #1  of TCGF sample.  Microplates were 
incubated at  37°C  in a  humidified atmosphere of 5%  CO2  in  air. After 22,  24,  or 48  h  of 
culture, 0.5 #Ci of [nH]thymidine (Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, 
N. Y.;  1.9 Ci/mM sp act) was added to each microplate well and cultured additional 6 or 24 
h. [aH]Thymidine incorporation was determined by scintillation counting. 
To assay for enhancement by TCGF of mitogen-induced responses in thymocytes or spleen 
T  cell subpopulations, 5  ×  10  ° cells in  RPMI-1640  supplemented with 0.5%  mouse serum, 
2ME, Hepes, and antibiotics, in 100 #1 were distributed in 96-well Microtest II plates (Linbro 
Chemical Co.); 100 pl of 0-25% purified TCGF-E was added, with or without 0.3 tag/ml of Con 
A. After 24 h of culture, 0.5 #Ci of [3H]thymidine was added; the cultures were harvested 24 h 
later. 
Purification Procedures.  Purification of TCGF-E was accomplished by Sephadex G-100 chro- 
matography (100- ×  2.6-cm column; pH 7.4; phosphate-buffered saline (PBS) eluent; constant 
flow elution of 15 ml/h) of various culture supernates after 50- to 70-fold concentration (Diaflo 
ultrafiher PM10; Amicon Corp., Lexington, Mass.). Standards for molecular weight estimation 
125  125T  included  I-bovine serum albumin,  I-Rauscher virus  P30 (kindly supplied by Dr. Charles 
125  3  Simrell  and  Dr.  Paul  Klein),  I-cytochrome  c,  and  [ H]-Con  A  (Radiochemical  Centre, 
Amersham, England). 
Assay for Cytotoxicity.  Cytotoxic activity was assessed  by a 51Cr-release assay system described 
in detail elsewhere (13). 
Results 
TCGF Production by  Murine  T-Lymphoma  Cell  Lines.  12  cultured  cell  lines  of T- 
lymphoma origin were investigated for spontaneous or induced production of TCGF 
under indentical conditions as shown  in Table I. None of the  12 T-lymphoma  lines 
produced TCGF spontaneously. Even 7- to 28-times-concentrated supernates and cell 
cytoplasm extracts of EL-4 azg  x contained no detectable TCGF  activity. In contrast 1438  StllMIZU  ET  AL.  BRIEF  DEFINITIVE  REPORT 
to the  10 other T-cell lines, both EL-4 and EL-4 azg  ~ secreted significant amounts of 
TCGF into culture supernates when stimulated by mitogens. Con A was most effective 
of all mitogens in inducing TCGF production by EL-4 and EL-4 azg  r. Production of 
TCGF-E was rapidly induced, detectable at 6 h, and maximal at  18-24 h. The dose- 
response,  time-course, and  cell-density  kinetics  are illustrated  in  Fig.  1.  Irradiation 
(5,000-7,000  rad)  did not affect TCGF production  by Con A-stimulated EL-4 azg  ~. 
LPS, a putative B cell mitogen, consistently stimulated low but significant production 
of TCGF-E in the EL-4 lines. This unexpected observation is still being investigated 
in light of previous studies suggesting that  LPS might have some role in stimulating 
thymus cells (14). 
Characterization of TCGF-E Obtained  from Con A-stimulated EL-4 azg ~.  Supernates from 
both  Con  A-stimulated  EL-4  azg  r and  Con  A-stimulated  murine  spleen  cells  were 
concentrated  50- to 70-fold and fractionated on Sephadex G-100:  Each fraction was 
assayed for Jail]Con A and for functional TCGF activity on a cloned cytotoxic T  cell 
line or on Con A blast cells. As shown in Fig. 2, TCGF-S and TCGF-E had identical 
peak activity in the fractions that contained the P30 marker, indicating a  molecular 
size on the order of 30,000 dalton, a size range clearly separable from that of [3H]Con 
A.  This  partially  purified  product  is  termed  PTCGF-E  and  was  used  in  studies 
reported below. 
Comparison of Various Biological Activities of TCGF-S and TCGF-E.  TCGF-E has been 
tested for each functional effect described for TCGF-S (1,  7-9). Nylon-wool-column- 
passed C57BL/6 spleen T  cells were very slightly stimulated or unaffected by PTCGF- 
E alone, but responded strongly to suboptimal concentrations of Con A  (0.3  p.g/ml) 
when very dilute PTCGF-E was added. Thymocytes responded minimally to Con A 
or to PTCGF-E alone, but proliferated in the presence of both as shown in Table II. 
LPS blasts generated from either C57BL/6  or C57BL/6  nu/nu  failed to proliferate 
with PTCGF-E. The growth supporting activity of PTCGF-E was generally equivalent 
upon  DBA/2-,  AKR-,  or  A/J-derived  T  cells,  indicating  no  strain  specificity.  In 
experiments  not  shown  here,  the  PTCGF-E  requirement  for  generating  cytotoxic 
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I"lc;.  I.  Time-course, cell densitv, and Con A-dose-response kinetics of TCGF-E production bv EL- 
4  azg".  EL-4  azg" cells  (5  X  10  ~ cells/ml  [&]:  I  X  1()  ~ cel[s/ml  [O]:  2  ×  10" cells/ml  [A])'were 
cultured  with  5,  10,  20,  or 40 p.g/ml of Con  A  for various intervals  in  5'~-FCS  culture  medium. 
Supernates were assayed fi)r TCGF activity on cell  line BAD-1.  [;~ltlThymidine  incorporation  was 
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Fta.  2.  Fractionation  of  TCGF-E  (A)  or  TCGF-S  (B)  by  Sephadex  G-100  chromatography. 
Concentrated TCGI'-E or TCGF-S was fractionated as described in  Materials and  Methods and 
each  fraction  was assayed for TCGF  activitv on  cell  fine  BAD-I  (A or  A) or Con  A  blasts  (O or 
0). lali]Thymidine incorporation was measu'red for the last  24 h  of the 72 h  incubation. [:JHJCon A 
(~)  was added  to  the  TCGF  before fractionation.  The peaks shown  represent  22~7, of the counts 
added to the column;  78'7< was bound to Sephadex G-I(X) at the application point. 
TABLE II 
PTCGF-E Effect on  Various Kinds of T-Cell Blasts, B Cell Blasts, Normal Spleen  T  Cells, or 
Thymocytes 
Cultured cells and conditions 
[:~H]Thymidine  incorporation: percent PTCGF-E: 
0  6  12  25 
mean tpm  ±  SD 
T  or B cell blasts* 
BAD-I CTL  214 ±  88  12,761 4-  1,923  36,205 zl: 4,172  52,661  ±  4,464 
BADCXA-2 allot*active T cell  478 ±  112  54,564:1:711  55,750 ±  928  53,129 ±  1,722 
C57BL/6 Con A blast  504 4-  134  32,050 4-  1,849  49,843  ±  1,741  60,740  ±  1,410 
C57BL/6 LPS blast  8,782 ~  584  10,070 ±  250  11,151  4- 200  10,437 __. 489 
C57BL/6 nude LPS blast  9,373 4- 597  12,241 4- 877  12,401 ±  70  12,392 +  329 
DBA/2 Con A blast  1,395 +  153  ND  39,780 +  1283  46,806  4-  1,000 
AKR Con A blast  892 :t:  135  ND  19,232 4-  1,166  33,378  +  1,917 
A/J Con A blast  936 :t: 247  ND  18,955 ±  761  28,965 4-  I,(~X) 
Spleen  cells and thymocytes:~ 
C57BL/6 spleen T cell  146 ±  11  656 :t: 42  1,409 -'r 30  2,606 ±  329 
C57BL/6 spleen  T  cell  +  Con A  (0.3  10,978  +  2,284  32,371 4- 2,666  57,228 ±  3,718  94,702 4-  1,700 
/ag/m}) 
C57BL/6 thymocyte  [58 ±  42  2,245 4- 403  2,572 +  172  3,548 ±  287 
C57BL/6 thymocyte +  Con A (0.3 ug/  2,023 :t: 510  23,461  ±  2,624  28,854 ±  325  35,773  +  3,052 
nd) 
After 24  h  of culture, 0.5/tCi  of [:~H]thymidine  was added; the cultures were harvested 24 h  later. The results  were 
expressed  as mean cpm ±  SD in triplicate cultures. ND, not determined. 
* 5 ×  l0  4 cells of each T cell blast  were cultured with or without indicated concentrations of PTCGF-E. 
:~ 5 X  10  ~  cells of nyhm-wca)l-column-passed  spleen cells or thymocytes were cultured with iudicated concentrations of Con 
A and/or PTCGF-E. 
activity against P815 target cells in C57BL/6 anti-DBA/2 mixed lymphocyte cultures 
was assayed on cells collected after  10 d  or after a  sixth restimulation in a  long-term 
culture.  Alloreactive  cells  alone  had  little  residual  cytotoxic  activity  15  d  after 1440  SHIMIZU  ET  AL.  BRIEF  DEFINITIVE REPORT 
restimulation.  30%  PTC2GF-E augmented cytotoxic activity to a  level even greater 
than that induced by specific stimulator cells. 
Discussion 
Evidence is presented that  a  variant of the EL-4 cell line  (EL-4 azg  r)  and,  to a 
lesser extent, the parental EL-4 line produced TCGF when stimulated by Con A. The 
producer lines carry the Lyt- 1 marker, whereas all nonproducer T  cell lines examined 
did  not.  Until  more  lines  with  Lyt-1  markers  are  examined,  however,  it  can  be 
concluded only that this phenotype identifies a Tc2GF-producer cell. However, it is 
consistent with the data of others that suggest that TC2GF production is a function of 
Lyt-l-bearing T  cells (3-5). 
Kinetic studies showed most TCGF-E production occurred early (6 h) after stimu- 
lation by Con A. Production of TC2GF-E was radiation resistant. Biochemical prop- 
erties and biological activity suggest strongly the indentity of TCGF-E and TC2GF-S, 
including: similar molecular weights, identical effects upon T  cell mitogen responses, 
T  cell blast  proliferation, generation  of cytotoxic T  cells,  absence of effects upon 
normal resting T  cells, and lack of strain specificity. 
Mitogen induction for TC2GF production by EL-4 azg  r appeared to be an absolute 
requirement. EL-4 azg  ~ produced no detectable TCGF-E intracellularly or extracel- 
lularly,  unless  stimulated  with  Con  A.  This  suggests  that  TCGF  production  is  a 
differentiated function of the  cell  line,  requiring  only a  specific signal  to  initiate 
synthesis and secretion of the product or products assayed as TCGF. In this case, the 
triggering effect is supplied  by a  lectin that  binds  to the cell surface without  any 
accessory cell requirement. This signal can also be supplied by binding of xenogeneic 
anti-Thy-1  sera  to  the  membrane  of EL-4  azg  x  (S.  Shimizu  and  R.  T.  Smith. 
Unpublished data.). Detectable low level secretion of TCGF was stimulated by PHA- 
P and LPS. 
An  FcR  +  (6,  15)  or  an  Ia  ÷  (1,  2)  accessory cell  is  required  to  induce  TCGF 
production by anti-Thy-1 antibody or Con A, respectively. Therefore, the EL-4 azg  ~ 
cell line appears to bypass the requirement for any signal provided by an accessory 
cell. If the accessory cell requirement is, as has been proposed (6), related to its role in 
augmenting translateral  aggregation by mitogen-bound glycoproteins in the T  cell 
membrane, then the T-lymphoma line EL-4 azg  r has acquired a capacity to accom- 
plish this unaided. That LPS can also stimulate minimal TCGF production in EL-4 
azg  x suggests that the bypassed accessory cell mechanism yields a less discriminating 
responsiveness than  normal  T  cells  in  terms of T  cell specificity of the  mitogenic 
stimulus. 
These observations suggest a  practical source of TCGF for use in further investi- 
gation of mechanisms of T  cell activation, and a more homogeneous source of TCGF 
for characterization of the molecule or molecules involved. Moreover, they provide a 
model cell in which to examine the signal mechanism by which membrane glycopro- 
tein binding can activate TC2GF synthesis and secretion. 
Summary 
Of 12 T-lymphoma cell lines investigated, one line, EL-4 azg  r (Thy-1  +, Lyt-1  +, Lyt- 
2-3-, Ia-, T-200  ÷, slg-, and FcR-) and, to a  lesser extent, the parental cell line, EL- 
4, produced T  cell growth factor(s)  (TCGF) when stimulated by the T-cell mitogen 
concanavalin A  (Con A). Induced production of TCGF-E was detected by 6 h  and 
maximal at  18-24 h. Purified TC2GF-E from this source had an ~30,000 mol wt and SItlMIZU ET AL.  BRIEF  DEFINITIVE REPORT  1441 
the biological activity of TCGF produced by whole spleen cells, including:  augmen- 
tation  of T  cell-mitogen  responses,  cytotoxic  T  lymphocyte  (CTL)  proliferation 
support  dependence,  augmented  generation  of CTL,  lack of strain  specificity,  and 
failure to stimulate  resting T  cells. TCGF-E is neither synthesized or secreted by this 
lymphoma cell line unless stimulated  by Con A. X-irradiation  up to 7,000 rad failed 
to inhibit synthesis and secretion. These observations have a  practical  application  in 
providing a relatively homogeneous clonal cell product for T  cell culture support and 
for structural  and  functional  studies  of the TCGF  molecule(s).  They suggest  also a 
model for examining mechanisms of triggering production and secretion of a  regula- 
tory molecule that controls T  cell functions. 
Received  for publication 28July 1980. 
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